Physician profile
Ross Passo
NPI 1831550466
$2,602.35
in general payments reported to CMS, 2019-2025
17 companies · $571 in 2025
The $571 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $136 · 2023: $318 · 2024: $1,577 · 2025: $571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,266 · Education: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,266.17 |
| Education | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $1,237.72 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Regeneron Healthcare Solutions, INC. | $351.32 | 2023-2025 | Eylea Hd, Eylea |
| Alcon Vision LLC | $260.81 | 2022-2025 | Centurion, Unity, Precision 1 |
| Abbvie INC. | $196.83 | 2023-2025 | |
| Biotissue Holdings INC. | $109.73 | 2025 | |
| Amgen INC. | $87.05 | 2024-2025 | Tepezza |
| Thea Pharma INC. | $68.81 | 2024-2025 | Iyuzeh |
| Johnson & Johnson Surgical Vision, INC. | $49.20 | 2025 | Veritas Vision System, Tecnis Iol, Tecnis Iol |
| Bausch & Lomb Americas INC. | $45.47 | 2024-2025 | Miebo, Vyzulta, Xiidra |
| Genentech USA, INC. | $36.16 | 2022 | |
| Oyster Point Pharma, INC. | $33.04 | 2022-2023 | Tyrvaya |
| Glaukos Corporation | $29.80 | 2022-2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| New World Medical,INC. | $22.99 | 2025 | Ahmed Glaucoma Valve, Clearpath, Kahook Dual Blade |
| Astellas Pharma US INC | $21.90 | 2025 | Izervay |
| Tarsus Pharmaceuticals, INC. | $18.53 | 2025 | Xdemvy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $18.27 | 2025 | Acthar |
| Sun Pharmaceutical Industries INC. | $14.72 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Passo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.